Table 1.
Study | Field strength | Sequence | Validation | Myocarditis (n) | Control (n) | Acute versus chronic cardiac inflammation | Control group | Test result | Sensitivity (%) | Specificity (%) | Diagnostic accuracy (%) | PPV (%) | NPV (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Laissy et al. Chest [21] | 1 T | T2w sequence with long TR/TE | Clinical | 20 | 7 | Acute | Healthy participants | Qualitative | 45 | 100 | 59 | 100 | 39 |
Abdel-Aty et al. J Am Col Cardiol [22] | 1.5 T | T2w triple inversion recovery sequence | Clinical | 25 | 23 | Acute | Healthy participants | ER cut off 1.9 | 84 | 74 | 79 | 78 | 81 |
Gutberlet et al. Radiology [23] | 1.5 T | T2w triple inversion recovery sequence | EMB | 48 | 35 | Chronic | Other diagnoses | ER cut off 2 | 67 | 69 | 68 | 74 | 60 |
Röttgen et al. Eur Radiol [24] | 1.5 T | T2w triple inversion recovery sequence | EMB | 82 | 49 | Acute | No inflammation on EMB | ER cut off 2 | 58 | 57 | 58 | 73 | 41 |
Voigt et al. Eur Radiol [25] | 1.5 T | T2w triple inversion recovery sequence | EMB | 12 | 11 | Chronic | No inflammation on EMB | ER cut off 1.8 | 92 | 82 | 87 | 85 | 90 |
Lurz et al. JACC Cardiovasc Imaging 26 | 1.5 T | T2w triple inversion recovery sequence | EMB | 53 | 17 | Acute | Other diagnoses | ER cut off 1.9 | 64 | 65 | 64 | 85 | 37 |
Lurz et al. JACC Cardiovasc Imaging [26]a | 1.5 T | T2w triple inversion recovery sequence | EMB | 30 | 32 | Chronic | Other diagnoses | ER cut off 1.9 | 42 | 66 | 54 | 58 | 50 |
Chu et al. Int J Cardiovasc Im [27] | 1.5 T | T2w triple inversion recovery sequence | Clinical | 35 | 10 | Acute | Healthy participants | Qualitative | 69 | 100 | 76 | 100 | 48 |
Ferreira et al. JACC Cardiovasc Imaging [28] | 1.5 T | Acquisition for cardiac unified T2 oedema sequence | Clinical | 50 | 45 | Acute | Healthy participants | ER cut off 2.2 | 67 | 55 | 61 | 78 | 42 |
Sramko et al. Am J Cardiol [29] | 1.5 T | T2w dark blood sequence | EMB | 15 | 27 | Chronic | Idiopathic DCM | ER cut off 1.9 | 13 | 93 | 64 | 51 | 66 |
Ferreira et al. J Cardiovasc Magn Reson [30] | 1.5 T | T2w triple inversion recovery sequence | Clinical | 60 | 50 | Acute | Healthy participants | ER cut off 2.0 | 48 | 86 | 65 | 81 | 58 |
Radunski et al. JACC Cardiovasc Imaging [31] | 1.5 T | T2w triple inversion recovery sequence | Clinical | 104 | 21 | Mostly Acute | Healthy Participants | ER cut off 2.2 | 76 | 42 | 70 | 84 | 30 |
Luetkens et al. Radiology [32] | 3 T | T2w triple inversion recovery sequence | Clinical | 24 | 42 | Acute | Healthy Participants | ER cut off 2.09 | 79 | 61 | 68 | 58 | 82 |
Schwab et al. Rofo [33] | 1.5 T | T2w triple inversion recovery sequence | Clinical | 43 | 35 | Acute | Healthy participants | Qualitative | 56 | 100 | 76 | 100 | 65 |
Hinojar et al. JACC Cardiovasc Imaging [34] | 1.5 T / 3 T | T2w triple inversion recovery sequence | Clinical | 61 | 40 | Acute | Healthy participants | Qualitative/ER | 56 | 94 | 71 | 95 | 55 |
Luetkens et al. Eur H J Cardiovasc im [35] | 1.5 T | T2w triple inversion recovery sequence | Clinical | 34 | 50 | Acute | Healthy participants | ER cut off 1.9 | 50 | 94 | 76 | 85 | 73 |
Pooled data | 696 | 494 | 62 | 76 | 67 | 78 | 58 | ||||||
Chronic inflammation only | 55 | 76 | 65 | 69 | 63 | ||||||||
Acute inflammation only | 63 | 76 | 68 | 80 | 57 | ||||||||
Healthy participants as control | 64 | 79 | 70 | 81 | 61 | ||||||||
Other diagnoses as controls | 58 | 69 | 63 | 73 | 54 |
DCM dilated cardiomyopathy, ER oedema ratio, EMB endomyocardial biopsy, NPV negative predictive value, PPV positive predictive value, TE echo time, TR repeat time; T2w T2 weighted
aOne study examining two groups of patients with acute and chronic cardiac inflammation